More PE attention is being paid to the US eye care market. Behind the record-setting numbers is a wave of add-on activity, which made up 88% of the 2021 count, Vector Medical Group reports.
While there are several PE-backed practices building nationwide footprints, most of the US ophthalmic market remains regionally focused. Consolidation opportunities remain, and as doctors begin to hit retirement age, PE deal activity is expected to stay strong. In partnership with Pitchbook, Vector Medical Group has released US Ophthalmic Market: A Wave of Consolidation. The report also features a Q&A with Vector CEO Dana Jacoby and Gary Herschman, a member of the Board of Directors at Epstein Becker Green. Read more.
